Brief: Hologic Receives FDA Approval For Aptima® Hpv Assay Primary Screening Option, Expanding Cervical Health Portfolio
04/02/2026 13:16
Feb 4 (Reuters) - Hologic Inc HOLX.O: HOLOGIC RECEIVES FDA APPROVAL FOR APTIMA® HPV ASSAY PRIMARY SCREENING OPTION, EXPANDING CERVICAL HEALTH PORTFOLIO Source text: ID:nBw4lqyMxa Further company coverage: HOLX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hologic
See all newsBrief: Blackstone And Tpg Complete Acquisition Of Hologic
Casey's General Stores edges higher ahead of replacing Hologic in S&P 500
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: S&P Dow Jones Indices Says Casey's General Stores Inc. Will Replace Hologic Inc. In The S&P 500 Effective Prior To The Market Open On April 9